Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

R. Bradley, J. Burrett, M. Clarke, C. Davies, F. Duane, V. Evans, L. Gettins, J. Godwin, R. Gray, H. Liu, P. McGale, E. MacKinnon, T. McHugh, S. James, P. Morris, H. Pan, R. Peto, S. Read, C. Taylor, Y. WangZ. Wang, M. Dowsett, J. F. Forbes, J. Ingle, A. Coates, J. Cuzick, M. Gnant, T. Aihara, J. Bliss, F. Boccardo, R. C. Coombes, P. Dubsky, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thürlimann, C. Van De Velde, M. Baum, A. Buzdar, I. Sestak, C. Markopoulos, C. Fesl, R. Jakesz, M. Colleoni, R. Gelber, M. Regan, G. Von Minckwitz, C. Snowdon, C. Geyer, Early Breast Cancer Trialists’ Collaborative Group

Internal Medicine

Research output: Contribution to journal › Article › peer-review

994 Scopus citations

Sort by
Weight
Alphabetically

Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

Fingerprint

Medicine & Life Sciences